Companies /Healthcare

10x Genomics Inc - Class A

NASDAQ: TXG Health Information Services
$64.28
â–² $0.02 (+0.02%) today
Markets open · 3:35pm ET
Today · % change

24/7 Wall St. View

Fundamentals

Market Cap
$8.4B
Profit Margin
-12.2%
Revenue (TTM)
$616.9M
EPS (TTM)
$-0.59
52-Week Range
$11 – $67
Street Target
$49.54

About 10x Genomics

10x Genomics Inc is a pioneering life science technology firm based in Pleasanton, California, specializing in developing instruments, consumables, and software for analyzing biological systems. Its innovative product lineup includes the Chromium and Visium platforms, offering solutions for single cell gene expression, immune profiling, and spatial analysis of biological samples. These tools are crucial for researchers in academia, government, and the biopharmaceutical industry, aiming to unlock complex biological insights at the cellular and molecular levels.

TXG Coverage

7:40pm ET
Investing

Cathie Wood’s Top Biotech Plays for February

Don’t look now, but Cathie Wood of Ark Invest is fresh off an impressive comeback year, with her broader basket of disruptive technology funds posting high double-digit percentage returns. Notably, the flagship…

Joey Frenette